文献速递疝与腹壁外科胃肠外科

中线剖腹术预防性使用补片预防切口疝后手术部位并发症的系统综述与随机临床试验Meta分析

Surgical site occurrence after prophylactic use of mesh for prevention of incisional hernia in midline laparotomy: systematic review and meta-analysis of randomized clinical trials.
PubMed 文献 · Surg Endosc · 2023-11-06

该Meta分析纳入15项随机临床试验共2344例患者,比较补片组与对照组切口疝和手术部位并发症的发生率。补片组切口疝发生率显著低于对照组(OR 0.29,95%CI 0.16-0.49,p=0.0001),手术部位并发症发生率高于对照组但无统计学显著性(OR 1.21,95%CI 0.85-1.72,p=0.0001)。净效应需治疗人数(NNT net)为5,作者认为补片使用仍对患者有益。

要点

  • 补片组切口疝发生率显著低于对照组(OR 0.29,95%CI 0.16-0.49,p=0.0001)。
  • 补片组手术部位并发症发生率高于对照组但无统计学显著性(OR 1.21,95%CI 0.85-1.72,p=0.0001)。
  • 净效应需治疗人数(NNT net)为5,作者认为补片使用仍对患者有益。

核心结论

  • 使用补片降低切口疝发生率且不增加手术部位并发症发生率,净效应需治疗人数(NNT net)为5,补片使用仍对患者有益。

研究设计与样本

  • 系统综述与随机临床试验Meta分析,按PRISMA指南进行,纳入15项已发表的临床试验,共2344例患者,使用随机效应模型分析。

主要发现

  • 补片组切口疝发生率显著低于对照组,OR为0.29(95%CI 0.16-0.49,p=0.0001)。
  • 补片组手术部位并发症发生率高于对照组,OR为1.21(95%CI 0.85-1.72,p=0.0001),但无统计学显著性。
  • 净效应需治疗人数(NNT net)为5,即平均需治疗5例患者才能使获益超过危害一个事件。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of mesh is the standard for the prevention of incisional hernia (IH). However, the effect of surgical site occurrence (SSO) has never been compared. The aim of this meta-analysis was to evaluate the prevalence of SSO and measure its negative effect through the calculation of the number needed to treat for net effect (NNT net). METHODS: A meta-analysis was performed according to the PRISMA guidelines. The primary objective was to determine the prevalence of SSO and IH, and the secondary objective was to determine the NNT net as a metric to measure the combined benefits and harms. Only published clinical trials were included. The risk of bias was analyzed, and the random effects model was used to determine statistical significance. RESULTS: A total of 15 studies comparing 2344 patients were included. The incidence of IH was significantly lower in the mesh group than in the control group, with an OR of 0.29 (95% CI 0.16-0.49, p = 0.0001). The incidence of SSO was higher in the mesh group than in the control group, with an OR of 1.21 (95% CI 0.85-1.72, p = 0.0001) but without statistical significance. Therefore, the way to compare the benefits and risks of each of the studies was done with the calculation of the NNT net, which is the average number of patients who need to be treated to see the benefit exceeding the harm by one event, and the result was 5, which is the average number of patients who need to be treated to see the benefit exceeding the harm by one event. CONCLUSION: The use of mesh reduces the prevalence of IH and it does not increases the prevalence of SSO, the NNT net determined that the use of mesh continues to be beneficial for the patient.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lozada Hernández EE, Maldonado Barrios IL, Amador Ramírez S, et al. Surgical site occurrence after prophylactic use of mesh for prevention of incisional hernia in midline laparotomy: systematic review and meta-analysis of randomized clinical trials. Surg Endosc. 2023. PMID: 37932603. doi:10.1007/s00464-023-10509-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。